These molecular alterations demonstrate that vascular risk in childhood obesity begins at the transcriptomic level long before clinical symptoms emerge, highlighting the <i>ATF6/PLAT</i> axis as a potential biomarker for early risk assessment. The gene discussed is ATF6; the disease is Obesity.